Hydrochloric Acid

Hydrochloric Acid

SCHEMBL437245

C=CCNC(C)NCC(=O)O.Cl

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTGS2 known ✓ P35354 1/20 0.34
ACE known ✓ P12821 1/20 0.30
MAPT P10636 3/20 0.34
ALDH1A1 P00352 2/20 0.34
LMNA P02545 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
ECE1 P42892 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
ABCC4 O15439 1/20 0.31
TSHR P16473 1/20 0.31
MME P08473 1/20 0.30
CPA1 P15085 1/20 0.30
ACE2 Q9BYF1 1/20 0.30
FAAH O00519 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1551333 0.98 MAPT (0.35) MAPTALDH1A1LMNAPTGS2TDP1
SCHEMBL3658182 0.91 MAPT (0.33) MAPTALDH1A1LMNAPTGS2TDP1
SCHEMBL8416121 0.78 SLC6A4 (0.38) ALDH1A1SMN1; SMN2NPC1RAB9ATSHR
SCHEMBL5570056 0.76 SLC6A4 (0.38) MAPTALDH1A1LMNAPTGS2TDP1
SCHEMBL3435876 0.76 MME (0.33) MAPTALDH1A1SMN1; SMN2ABCC4TSHR
Sarcosine SCHEMBL27418475 0.73 ALDH1A1 (0.33) MAPTALDH1A1LMNAPTGS2TDP1
SCHEMBL23501484 0.73 ALDH1A1 (0.40) MAPTALDH1A1LMNAPTGS2TDP1
SCHEMBL22364723 0.72 MAPT (0.41) MAPTALDH1A1LMNAPTGS2TDP1
SCHEMBL725364 0.71
SCHEMBL253527 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2420141-B1 Methods of reducing phytotoxicity of a pesticide ORO AGRI INC (US) 2016-10-12 EP claimed
WO-2012074486-A1 MILK-BASED PESTICIDAL FORMULATION ORO AGRI INTERNATIONAL LTD (KY) 2012-06-07 WO claimed
EP-2420141-A1 Methods of reducing phytotoxicity of a pesticide Oro Agri, Inc (US) 2012-02-22 EP claimed
US-20240116831-A1 Methods and Compositions for Soil Regeneration and Improved Soil Hydrology U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT 2024-04-11 US disclosed
WO-2023069313-A1 METHODS AND COMPOSITIONS FOR SOIL REGENERATION AND IMPROVED SOIL HYDROLOGY LOCUS SOLUTIONS IPCO, LLC (US) 2023-04-27 WO disclosed
US-20210290690-A1 COMPOSITIONS OF MORSELIZED UMBILICAL CORD AND/OR AMNIOTIC MEMBRANE AND METHODS OF USE THEREOF U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION 2021-09-23 US disclosed
US-11116800-B2 Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof TISSUETECH, INC. (US) 2021-09-14 US disclosed
US-20210276929-A1 MICROBIAL SOIL ENHANCEMENT LE KHANH (US) 2021-09-09 US disclosed
US-20210230081-A1 MICROBIAL SOLUTION LE KHANH (US) 2021-07-29 US disclosed
WO-2021132019-A1 AGENT FOR IMPROVING CUTANEOUS RESIDENT FLORA BALANCE 株式会社林原 2021-07-01 WO disclosed
US-10899676-B2 Animal feed stock using microbial enhancement Cisbay Global Inc. (US) 2021-01-26 US disclosed
EP-0371564-A2 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1990-06-06 EP disclosed
EP-0371559-A2 Use of benzimidazoles in the treatment of epithelial disorders JANSSEN PHARMACEUTICA N.V. (BE) 1990-06-06 EP disclosed
EP-0344708-A2 Composition for external application to skin LION CORPORATION (JP) 1989-12-06 EP disclosed
EP-0335442-A2 Agents for preserving or restoring the soundness of the skin JANSSEN PHARMACEUTICA N.V. (BE) 1989-10-04 EP disclosed
EP-0332847-A2 Composition for preventing graying of the hair and restoring grayed hair to its natural color LION CORPORATION (JP) 1989-09-20 EP disclosed
EP-0294808-A1 Agent for external application and use thereof LION CORPORATION (JP) 1988-12-14 EP disclosed
EP-0293837-A2 Composition for application to hair or scalp Sugiyama, Keikichi (JP) 1988-12-07 EP disclosed
EP-0260697-A2 Composition for application to hair LION CORPORATION (JP) 1988-03-23 EP disclosed
EP-0256472-A2 Cosmetic agent for application to skin LION CORPORATION (JP) 1988-02-24 EP disclosed